BIOTRONIK and Egg Medical Form Strategic Alliance to Improve Radiation Protection for Interventional Healthcare Workers

BIOTRONIK, a global leader in cardiovascular, endovascular, and neuromodulation solutions, today announced it is partnering with Egg Medical, Inc., a global leader in radiation protection technology, to co-sell Egg Medical’s EggNest™ Radiation Protection Systems for healthcare workers in the United States.

The EggNest Systems (EggNest XR, EggNest Protect & EggNest Complete) are innovative radiation protection platforms that can be used across a wide variety of fluoroscopy procedure types without impacting workflow. The EggNest Systems are the only products commercially available in the US able to protect everyone in the interventional suite. Radiation reductions of up to 97% are possible with EggNest XR and EggNest Protect, and up to 99% reductions are possible with EggNest Complete.1

“Partnering with companies like Egg Medical in the radiation protection space allows BIOTRONIK to bring our vision of ‘Excellence for Life’ to healthcare professionals as well as their patients.  These products will allow us to bring a safer environment to every member of the EP lab, Cath lab, and other procedure suites,” said Matt Roberts, VP, National and Corporate Accounts at BIOTRONIK.

“We are thrilled to partner with BIOTRONIK, who has been focused on providing radiation protection to their customers for many years. This partnership expands our ability to provide protection for everyone in the procedure room across the US,” said Gavin Philipps, Chief Commercial Officer at Egg Medical.

More Articles from the Medical Industry

TATE & LYLE RECEIVES INNOVATION IN HEALTH TECHNOLOGY PRODUCT AWARD

Tate & Lyle’s Jessie Han, Sales Director, Greater China, accepts the award Shanghai, China – 25 June 2026 – Tate …

Inaugural Smart Health Asia Opens in Singapore: 80 sessions with more than 140 senior speakers from 18 countries

From left to right: Ms. Ong Huey Hong (Assistant Chief Executive (Industry Development Group), Singapore Tourism Board), Mr. Alvin Tan …

Agilent and Singapore’s NATi Partner to Advance Lipid Conjugated Oligonucleotide Research  

Collaboration expands research of new delivery platform beyond liver tissues supporting potential preclinical development and strengthens Singapore’s position as a …

REHACARE CHINA Forges Strategic Partnership with National Development and Supply Center of Assistive Products —— A Powerful Alliance Connecting Global Markets

Messe Düsseldorf (Shanghai) Co., Ltd., the organizer of REHACARE CHINA, enters into a strategic partnership with the National Development and …
Share via
Copy link